Shang, Q., Lin, Z., Plichta, J., Thomas, S., Ouyang, M., Luo, S., & Wang, X. (2026). Comprehensive Analysis and Prediction of HER2-Targeted Therapy Insensitivity Among HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Treatment. Cancers, 18(6), 989. https://doi.org/10.3390/cancers18060989
Chicago Style (17th ed.) CitationShang, Qingyao, Zian Lin, Jennifer Plichta, Samantha Thomas, Meishuo Ouyang, Sheng Luo, and Xin Wang. "Comprehensive Analysis and Prediction of HER2-Targeted Therapy Insensitivity Among HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Treatment." Cancers 18, no. 6 (2026): 989. https://doi.org/10.3390/cancers18060989.
MLA (9th ed.) CitationShang, Qingyao, et al. "Comprehensive Analysis and Prediction of HER2-Targeted Therapy Insensitivity Among HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Treatment." Cancers, vol. 18, no. 6, 2026, p. 989, https://doi.org/10.3390/cancers18060989.